| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 45.7% | 21/46 |
| Female | 32.6% | 15/46 |
| Indifferent | 0% | 0/46 |
| Unknown | 21.7% | 10/46 |
| General | ||
| 39.1% | 18/46 | |
| 47.8% | 22/46 | |
| 28.3% | 13/46 | |
| 87% | 40/46 | |
| 54.3% | 25/46 | |
| 78.3% | 36/46 | |
| 56.5% | 26/46 | |
| 23.9% | 11/46 | |
| 41.3% | 19/46 | |
| 56.5% | 13/23 | |
| Neurology | ||
| 45.7% | 21/46 | |
| 13% | 6/46 | |
| 43.5% | 20/46 | |
| Facial abnormalities | ||
| 32.6% | 15/46 | |
| 34.8% | 16/46 | |
| 60.9% | 28/46 | |
| 65.2% | 30/46 | |
| Visual and hearing impairments | ||
| 15.2% | 7/46 | |
| 39.1% | 18/46 | |
| Heart | ||
| 26.1% | 12/46 | |
| Pulmonary | ||
| 47.8% | 22/46 | |
| Gastrointestinal | ||
| 37% | 17/46 | |
| Urogenital | ||
| 23.9% | 11/46 | |
| Skeleton | ||
| 91.3% | 42/46 | |
| Skin / Hair / Nails | ||
| 71.7% | 33/46 | |
| Endocrine / Immunological / Metabolic | ||
| 8.7% | 4/46 | |
| 8.7% | 4/46 | |
| 52.2% | 24/46 | |
| Neoplasia | ||
| Neoplasia | 0% | 0/46 |
| Inheritance | ||
| 100% | 45/45 | |
